Nano Medicevo Acquires Assets, Intellectual Property and Retains R&D Team from APL Medical Surgery Technologies

The company adds advanced surgical image analytics technology capabilities to its digital laparoscopy platform and will establish a new R&D Center

Nano Medicevo (ISIN: JP3630033300), a privately-held medical company that offers products and services to advance the entire medical treatment process from diagnosis to post treatment care, is pleased to announce that it has acquired substantially all of the assets of APL Medical Surgery Technologies, a medical technology company, in a cash and stock transaction. APL is a pioneer in the field of surgical technology, having developed a software-based image analytics platform powered by advanced visualization, scene recognition, artificial intelligence, machine learning and data analytics.
"Adding innovative, novel technological capabilities to NanoPrecision(TM) Robotic Surgical System is a critical part of our long-term strategy as we work towards digitizing the interface between the surgeon and the patient," said Seigo M. Iwasaki, President and CEO of Nano Medicevo. "The addition of the APL technology to our NanoPrecision(TM) Robotic Surgical System will increase the effectiveness of surgeons, making procedures quicker and less error-prone, leading to better outcomes for the patient."
"We are very excited to be partnering with Nano Medicevo, one of the leaders in surgical robotics who is pioneering the industry with their platform". "The NanoPrecision(TM) Robotic Surgical System is a fantastic product with incredible potential, and we have a shared vision with Nano Medicevo of providing digital laparoscopy to better equip surgeons with innovative technologies that enhance their abilities, providing better quality, more consistent outcomes."
The addition of APL's technology, IP portfolio, and R&D team supports and accelerates Nano Medicevo's vision to leverage its NanoPrecision(TM) Robotic Surgical System to deliver digital laparoscopy, thereby increasing control in the surgical environment and reducing surgical variability.
Innovative Surgical Technology Portfolio: APL's technology and software engine will help accelerate NanoPrecision(TM) Robotic Surgical System platform innovation to meaningfully advance the benefits of digital laparoscopy to patients, surgeons and operating rooms globally. Key components of APL's technology include advanced visualization, scene recognition, artificial intelligence, machine learning and data analytics.

Nano Medicevo
Address: The Tower Yokohama Kitanaka, 5 Chome Kitanakadori, Naka Ward, Yokohama, Kanagawa 231-0003, Japan
peter.stefanov@nanomedicevo.com
Peter Stefanov

About Nano Medicevo
Nano Medicevo is a privately-held medical company focused on developing advanced surgery systems and miniaturized robots for general surgery procedures. Nano Medicevo has set out to transform robot-assisted surgery, with proprietary technology that has the potential to far surpass today's best solutions. Providing unprecedented access and maneuverability, the Nano Medicevo's NanoPrecision(TM) Robotic Surgical System features miniature, humanoid-shaped robotic arms with human dexterity, superhuman flexibility, and 360? articulation for various access configurations. Nano Medicevo Surgery Systems' mission is to innovate, support and simplify illness fighting solutions everywhere so we can realize our vision of living in a disease-free world.

This release was published on openPR.